Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Men and women experience skin aging differently due to changes in sex hormone levels with age.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Older age, obesity, hirsutism, and having children increase metabolic risk in women with PCOS.

PCOS increases the risk of heart disease and type 2 diabetes in women.

Electric current quickly reduces hand sweating but the effect doesn't last long.

Postmenopausal women often experience hair loss on the scalp and increased facial hair, but iron supplements may not help.

In 2009, there were new medical devices, treatments for gynecological conditions, updated health guidelines, and legal developments in women's health.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

Healthy aging can be promoted through physical activity, lifestyle changes, and certain treatments.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

Early signs of PCOS in girls, like irregular periods and polycystic ovaries, suggest a need for early diagnosis and intervention to prevent further health issues.

Minoxidil and finasteride combined can effectively treat hair loss.

Hair loss can cause significant social and emotional issues, especially for women and young men.

Poor sleep and high stress are linked to skin, scalp, and hair problems.

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

The document likely offers guidance on treating a woman's excessive hair growth, considering her symptoms and obesity.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Women with PCOS are more likely to have impaired glucose tolerance and type 2 diabetes, especially if they are Asian or obese.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.